HR 5150 · 115th Congress 2017–2019, ended

Protecting Medicare from Excessive Price Increases Act of 2018

Latest action · Mar 9, 2018 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 1, 2018
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Protecting Medicare from Excessive Price Increases Act of 2018

This bill requires a drug manufacturer to pay a Medicare rebate on a single-source drug or biological in accordance with the extent to which the manufacturer's average sales price for the drug or biological increases faster than inflation.

Cosponsors 4

Members who signed on, in the order they did. Signatures ran from Mar 13, 2018 to Apr 18, 2018.

SeatCosponsorSigned on
D-OREarl BlumenauerMar 13, 2018
D-TXSheila Jackson LeeMar 13, 2018
D-AZRaúl M. GrijalvaApr 10, 2018
D-CAJudy ChuApr 18, 2018

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Mar 1, 2018
Health Subcommittee
Referred Mar 2, 2018
HouseWays and Means Committee
Referred Mar 1, 2018
Health Subcommittee
Referred Mar 9, 2018

Actions 4

Everything that happened, newest first.

  1. Mar 9, 2018Referred to the Subcommittee on Health.
  2. Mar 2, 2018Referred to the Subcommittee on Health.
  3. Mar 1, 2018Introduced in House
  4. Mar 1, 2018Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8, Clause 1 of the United States Constitution

The sponsor’s statement, as printed in the Congressional Record, vol. 164, no. 37, March 1, 2018, page H1342.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend title XVIII of the Social Security Act to require drug manufacturers to pay a Medicare part B rebate for certain drugs if the price of such drugs increases faster than inflation.
Short Titles as Introduced
Protecting Medicare from Excessive Price Increases Act of 2018

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Mar 1, 2018Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.